The Procter & Gamble Company Deferred Income Tax Liabilities, Net
The Procter & Gamble Company (PG) had Deferred Income Tax Liabilities, Net of $5.76 billion as of 2026-06-30, per its 10-K filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-04
- 2026-06-30: Deferred Income Tax Liabilities, Net $5.76B.
- 2026-03-31: Deferred Income Tax Liabilities, Net $6.05B.
- 2025-12-31: Deferred Income Tax Liabilities, Net $5.97B.
- 2025-09-30: Deferred Income Tax Liabilities, Net $5.89B.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $5.76B 10-K · filed 2026-08-04 |
| 2026-03-31 | $6.05B 10-Q · filed 2026-04-24 |
| 2025-12-31 | $5.97B 10-Q · filed 2026-01-23 |
| 2025-09-30 | $5.89B 10-Q · filed 2025-10-24 |
| 2025-06-30 | $5.77B 10-K · filed 2026-08-04 |
| 2025-03-31 | $6.48B 10-Q · filed 2025-04-24 |
| 2024-12-31 | $6.72B 10-Q · filed 2025-01-22 |
| 2024-09-30 | $6.42B 10-Q · filed 2024-10-18 |
| 2024-06-30 | $6.52B 10-K · filed 2025-08-04 |
| 2024-03-31 | $6.28B 10-Q · filed 2024-04-19 |
| 2023-12-31 | $6.22B 10-Q · filed 2024-01-23 |
| 2023-09-30 | $6.81B 10-Q · filed 2023-10-18 |
| 2023-06-30 | $6.48B 10-K · filed 2024-08-05 |
| 2023-03-31 | $6.42B 10-Q · filed 2023-04-21 |
| 2022-12-31 | $6.46B 10-Q · filed 2023-01-19 |
| 2022-09-30 | $6.99B 10-Q · filed 2022-10-19 |
| 2022-06-30 | $6.81B 10-K · filed 2023-08-04 |
| 2022-03-31 | $6.54B 10-Q · filed 2022-04-20 |
| 2021-12-31 | $6.51B 10-Q · filed 2022-01-19 |
| 2021-09-30 | $6.32B 10-Q · filed 2021-10-19 |
| 2021-06-30 | $6.15B 10-K · filed 2022-08-05 |
| 2021-03-31 | $5.98B 10-Q · filed 2021-04-20 |
| 2020-12-31 | $6.07B 10-Q · filed 2021-01-20 |
| 2020-09-30 | $6.29B 10-Q · filed 2020-10-20 |
| 2020-06-30 | $6.20B 10-K · filed 2021-08-06 |
| 2020-03-31 | $6.31B 10-Q · filed 2020-04-20 |
| 2019-06-30 | $6.90B 10-K/A · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |